Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

NCT04827875 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Keloid
Scar
Incision
Excision Margin

Interventions

DRUG: AIV001

Sponsor

AiViva BioPharma, Inc.